Sorry, we didn't find any business matching “Twiddy-R-R-Dr” in “Ritchot MB”. We've expanded your search to include associated keywords in hopes of returning listings that may help you.
I have been a patient of Dr Babicks for 25+ years and he has always been there for me. I have had a lot of health issues over the last 15 years and he has helped me find some of the best specialists you could ask for. I personally couldn't give him enough stars:)Read more
We offer reliable and affordable painting in the Eastern Manitoba District. D & R Painting only uses quality paints, primers and stains on every job. Call us now for an estimate!
Turning Agri-Food ideas Into Healthy OpportunitiesOur VisionEstablish Manitoba as a nationally and internationally recognized centre of research, production, marketing, development and commercialization of agricultural products for health.Our MissionPromote and support the development of a strong functional food, food ingredient and natural health products research community and industry in Manitoba.World Class – Manitoba BasedManitoba Agriculture Investment – interiorBackgroundLocated in Winnipeg, Manitoba Canada in heart of the Canadian Prairies, MAHRN promotes Manitoba's capacity and capabilities for the testing and assessment of plant and animal-based bioactive compounds, from isolation and characterization through clinical proof of safety and efficacy to product development and commercialization.MAHRN supports the commercialization of these bioactives as functional foods, food ingredients and natural health products through project coordination, communications, outreach and test market services.
ContactEnhanced Accelerator ModelFounded in 1997 by renowned bio-entrepreneur Dr. Albert D. Friesen, the GVI team has extensive experience in technology development to offer its clients. The Company provides services to client companies through an enhanced accelerator model and active participation. GVI takes the idea of an incubator to the next level, becoming actively involved with each new venture and offering a tailored mix of services vital to successfully develop a technology that will address market opportunities.State of the ArtGVI believes that entrepreneurs on the leading edge of new and innovative technologies can benefit from a location that complies with the highest standards needed for the industry. To that end, GVI is situated in a newly constructed facility that houses both the GVI research and management staff, and several client companies. The custom designed building provides access to business structure and state of the art equipment.Building ValueA proven track record and an experienced and talented team make Genesys Venture Inc. a unique vehicle for developing innovative ventures.
Murray Chevrolet is a dealership in Winnipeg, MB, specializing in the sale of new and used Chevrolet vehicles, offering comprehensive services including financing, maintenance, and collision repair.
Ryan and Josh had helped me trade in my old vehicle for a new one and both of them were very pleasant to try and negotiate around this deal. Thanks to them, I have a new car! I would recommend others to pick Murray Chevrolet in looking for a new vehicle. Read more
Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.